Emily Hammad Mrig, PhD, MA, is an Assistant Professor in the Department of Clinical Pharmacy and at the Center for Translational and Policy Research on Precision Medicine (TRANSPERS) at the University of California, San Francisco. She holds a PhD in Health and Behavioral Sciences from the University of Colorado Denver and completed a postdoctoral fellowship in Health Policy and Management at Yale University.

Her research investigates disparities in healthcare access, with a focus on precision medicine, cancer, and undiagnosed/rare conditions. Dr. Mrig is the recipient of an NIH-NHGRI K01 Career Development Award examining payment pathways for molecular diagnostics and serves as Co-Investigator on a Department of Defense study aimed at improving the delivery of germline testing in Veterans with advanced prostate cancer, and an NHGRI R01 project focused on evidence-based and efficient precision medicine implementation.

Her current work employs innovative mixed-methods approaches, including AI-based techniques alongside traditional analyses of electronic health records, as well as patient narrative elicitation and multistakeholder engagement, to identify cost barriers to molecular diagnostics and targeted cancer therapies and to generate evidence supporting the equitable adoption of precision medicine technologies. She has published in high-impact journals such as Genetics in Medicine and the Journal of Health Policy, Politics & Law, and was recognized as a UCSF Population Health and Health Equity Scholar and recipient of the 2026 UCSF Emerging Scholar Award.